🛡️ Public data only — no PHI permitted on this instance.
SC
SeekingChartis
Investment Committee Memorandum | CA | 30 beds | Grade C | EBITDA uplift $5.1M
Investment Committee Memorandum

BARSTOW COMMUNITY HOSPITAL

CCN 050298 | SAN BERNARDINO, CA | 30 beds | April 26, 2026
EBITDA BridgeData Room
C
Investability

1. Target Overview & Investment Thesis

BARSTOW COMMUNITY HOSPITAL is a 30-bed suburban community hospital in SAN BERNARDINO, CA with $69.6M in net patient revenue and a 10.7% operating margin. The hospital serves a payer mix of 18.8% Medicare, 4.0% Medicaid, and 77.2% commercial.

Thesis: Turnaround. Our ML models identify $5.1M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from 10.7% to 18.0% (+736bps).

Net Revenue HCRIS$69.6M
Current EBITDA COMPUTED$7.4M
Operating Margin COMPUTED10.7%
Occupancy HCRIS63.9%
Revenue / Bed COMPUTED$2.3M
Net-to-Gross HCRIS12.5%
Distress Probability ML40.8%

2. Market Context & Competitive Position

414
CA Hospitals
-4.9%
State Median Margin
77
Comparable Hospitals

CA has 414 Medicare-certified hospitals with a median operating margin of -4.9%. The target's margin of 10.7% places it above the state median. Among 77 size-comparable peers (15-60 beds), the median margin is -6.1%. The target performs in line with or above peers.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (15-60), prioritizing same-state peers. 77 hospitals in the comp set.

HospitalStateBedsRevenueMargin
BARSTOW COMMUNITY HOSPITAL (Target)CA30$69.6M10.7%
USC NORRIS CANCER HOSPITALCA60$468.7M19.1%
TAHOE FOREST HOSPITALCA25$264.3M13.0%
PORTERVILLE DEVELOPMENTAL CENTCA17$193.6M-6.0%
ADVENTIST HEALTH REEDLEYCA49$187.1M1.8%
SUTTER DAVIS HOSPITALCA48$176.9M12.5%
ADVENTIST HEALTH UKIAH VALLEYCA50$173.4M-39.9%
ADVENTIST HEALTH CLEARLAKECA25$159.9M-6.3%
ST ELIZABETH COMMUNITY HOSPTICA49$159.2M3.5%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $5.1M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$1.5M+210bp18mo
Cost to Collect4.5%2.5%$1.4M+200bp12mo
Denial Rate Reduction12.0%6.5%$1.4M+198bp12mo
A/R Days Reduction5200.0%3800.0%$847K+122bp9mo
Clean Claim Rate88.0%96.0%$45K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$1.5M
Cost to Collect
$1.4M
Denial Rate Reduction
$1.4M
A/R Days Reduction
$847K
Clean Claim Rate
$45K
Total EBITDA Uplift$5.1M
Current EBITDA$7.4M
+ RCM Uplift+$5.1M
Pro Forma EBITDA$12.6M
Current Margin10.7%
Pro Forma Margin18.0%
WC Released (1x)$2.7M

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$11.4M$100.3M8.77x54.4%
Base (11x exit)10.0x11.0x$11.4M$114.0M9.97x58.4%
Bull Case9.0x11.0x$10.3M$134.6M13.09x67.2%
Bull (12x exit)9.0x12.0x$10.3M$149.9M14.57x70.9%
Bear Case11.0x10.0x$12.6M$70.9M5.64x41.3%
Bear (11x exit)11.0x11.0x$12.6M$82.1M6.53x45.5%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
LowLow net-to-gross ratioLarge contractual allowances suggest pricing discipline issues. Mitigant: payer renegotiation is an additional upside lever

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 77 hospitals with 15-60 beds
  • Same-state prioritization (n=78)
  • Comp margins: P25=-16.8% / P50=-6.1% / P75=1.8%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.

Full EBITDA BridgeML AnalysisHospital ProfileStatistical ProfileDeal Screener